e2 was 51 at 120mg test cyp/week
then was prescribed .5 eod -> ~.5-1 e2
.25 eod -> 5 e2
.25 e3d -> latest lab
although blood test that read 51 may have been day or two following a weekend of heavy drinking if that would have that much of an impact, this was July
i think i'd like to reduce my .25 e3d dosage opposed to no Aromatase inhibitor (AI) at all, I just don't know how I could reliably cut the pill another 1 or 2 times
Okay so current protocol is 140mg test cyp/week, 250IU Human Chorionic Gonadotropin (HCG) 2x/week, and .25 arimidex e3d
these are my latest labs, this is the first time i did a 24 hour urine lab
Estrone(E1) 1.8 LOW Range = 3-12 ug
Estradiol(E2) .9 Range = 0-7 ug
Estriol(E3) 1.2 = Range =...
bump
anyone care to explain this for me?
does the fact I have low shbg mean that adding more test won't do anything further for me or what?
I don't understand what binds with what and whether being bound is negative or positive
do you think that's necessary with my SHBG being that low?
In other words does it even matter the amount of exogenous test I'm injecting if theres that little shbg
i am working with a dr but not really getting a lot of guidance
my E2 was less than 1 when I was taking .5mg eod, and i started taking less on my own without a suggestion from doc
as far as the latest being 5, he said bumping the test cyp up should boost my e2 as well
i started taking 4, 1000IU vitamin D daily recently
i dont have a clue about how the IUs work with vit D, should i be taking more than this?
also, I'm going to stop arimidex for a week and then start either .25 e3d or ......? any suggestions
23 yo, trt for 6-7 months, latest labs
no history of steroid use or anything
used accutane in high school, and shortly after began ssri's for about 4 years
libido completely shot, ejaculatory anhedonia etc....
tested a handful of times in the 149-350 ngdl range
off of everything now aside...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.